March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Intravitreal Ranibizumab For Choroidal Neovascularizarion Reduces Significantly Chorioretinal Blood Flow Measured By Laser Speckle Flowgraphy
Author Affiliations & Notes
  • Yuki Maekawa
    Department of Ophthalmology & Vis Sci, Nagasaki Univ Grad Sch of BioMed Sci, Nagasaki, Japan
  • Kiyoshi Suzuma
    Department of Ophthalmology & Vis Sci, Nagasaki Univ Grad Sch of BioMed Sci, Nagasaki, Japan
  • Youko Miura
    Department of Ophthalmology & Vis Sci, Nagasaki Univ Grad Sch of BioMed Sci, Nagasaki, Japan
  • Eiko Tsuiki
    Department of Ophthalmology & Vis Sci, Nagasaki Univ Grad Sch of BioMed Sci, Nagasaki, Japan
  • Harumi Wakiyama
    Department of Ophthalmology & Vis Sci, Nagasaki Univ Grad Sch of BioMed Sci, Nagasaki, Japan
  • Takashi Kitaoka
    Department of Ophthalmology & Vis Sci, Nagasaki Univ Grad Sch of BioMed Sci, Nagasaki, Japan
  • Footnotes
    Commercial Relationships  Yuki Maekawa, None; Kiyoshi Suzuma, None; Youko Miura, None; Eiko Tsuiki, None; Harumi Wakiyama, None; Takashi Kitaoka, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 4177. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yuki Maekawa, Kiyoshi Suzuma, Youko Miura, Eiko Tsuiki, Harumi Wakiyama, Takashi Kitaoka; Intravitreal Ranibizumab For Choroidal Neovascularizarion Reduces Significantly Chorioretinal Blood Flow Measured By Laser Speckle Flowgraphy. Invest. Ophthalmol. Vis. Sci. 2012;53(14):4177.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Laser speckle flowgraphy (LSFG) (LSFG-Navi, Softcare, Fukuoka, Japan) is a new instrument for measuring and mapping blood flow of the ocular fundus. We investigated the chorioretinal blood flow and observed the blood flow map using LSFG before and after intravitreal ranibizumab (IVR) injection in patients with choroidal neovascularization (CNV).

Methods: : Twenty-three eyes of 23 patients (15 males and 8 females, mean age 70.0+/-11.7) with naïve CNV associated with typical age-related macular degeneration (12 eyes), polypoidal choroidal vasculopathy (5 eyes), pathological myopia (5 eyes) and idiopathic CNV (1 eye) were examined for the retinal blood flow at the optic disc and the chorioretinal blood flow at the macula using LSFG before and 1 month after each introductory IVR injection (one injection per month over 3 months) and evaluated using the mean blur rate (MBR).

Results: : The central macular thickness significantly decreased from 447+/-200µm to 318+/-107µm, 296+/-120µm, 276+/-118µm after 1st, 2nd and 3rd IVR respectively (p<0.01, Dunnett test in all period). Compared to before the IVR, the average MBR of the blood flow in the main retinal vessels at the disc area slightly decreased after the 1st (94.5+/-15.7%), 2nd (95.7+/-14.7%) and 3rd (97.5+/-15.5%) IVR, but exhibited no statistically significant difference after each IVR (p=0.15, repeated measures ANOVA). The average MBR of the chorioretinal blood flow at the macula reduced significantly after the 1st (91.5+/-12.0%, p<0.05, Dunnett test) and 2nd (89.2+/-14.5%, p<0.01, Dunnett test) IVR, although the difference disappeared after the 3rd IVR (94.4+/-14.8%). The blood flow maps visualized by LSFG detected CNV in 10 cases and also observed the reduction in blood flow at the CNV lesion in 6 cases.

Conclusions: : IVR indicated no significant difference in the retinal blood flow at the disc area, but significant decrease in the chorioretinal blood flow at the macula after the 1st and 2nd time. The difference in response to IVR between retinal main vessels and chorioretinal blood flow might be caused by the lack of a blood flow autoregulation system in the choroid. LSFG might be a valid measurement to evaluate the effect of treatment for CNV.

Keywords: choroid: neovascularization • imaging/image analysis: clinical • age-related macular degeneration 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×